Director/PDMR Shareholding

RNS Number : 1682Z
Genus PLC
16 September 2009
 

16 September 2009

FOR IMMEDIATE RELEASE 

Genus plc

('Genus' or 'the Company')

PDMR Shareholding


The Company has been notified that today, Ian Biggs, Chief Operating Officer for the Americas sold 26,777 ordinary shares of 10 pence each in the Company ('Shares'), Thomas Philip Acton, Chief Operating Officer for Europe and The Far East sold 8,380 Shares and Steve Amies, Chief Operating Officer for Global Research & Product Development sold 8,380 Shares. All sales were at a price of 709 pence per Share.


Ian Biggs' direct shareholding in the Company stands at 3,375 Shares representing 0.006% of the issued share capital of the Company that is currently 59,563,973 Shares. In addition, he is the beneficial owner of 116,490 conditional shares and nil-cost options


Thomas Philip Acton's direct shareholding stands at 29,484 Shares representing 0.049% of the issued share capital of the Company. In addition, he is the beneficial owner of 109,185 conditional shares and nil-cost options.


Steve Amies' direct shareholding stands at 8,380 Shares representing 0.014% of the issued share capital of the Company. In addition, he is the beneficial owner of 58,623 conditional shares and nil-cost options.


For further information please contact:

Ian Farrelly 

Group Company Secretary & General Counsel

Genus plc

Tel: 01256 345996


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUNAORKRRKAAR

Companies

Genus (GNS)
UK 100

Latest directors dealings